4D Molecular Therapeutics Inc (FDMT)
7.975
-0.44
(-5.17%)
USD |
NASDAQ |
Nov 21, 16:00
7.975
0.00 (0.00%)
After-Hours: 20:00
4D Molecular Therapeutics Market Cap: 368.67M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 388.78M |
| November 19, 2024 | 400.79M |
| November 18, 2024 | 384.61M |
| November 15, 2024 | 408.19M |
| November 14, 2024 | 370.75M |
| November 13, 2024 | 356.42M |
| November 12, 2024 | 363.81M |
| November 11, 2024 | 419.61M |
| November 08, 2024 | 422.21M |
| November 07, 2024 | 430.53M |
| November 06, 2024 | 434.17M |
| November 05, 2024 | 436.25M |
| November 04, 2024 | 425.07M |
| November 01, 2024 | 420.91M |
| October 31, 2024 | 416.49M |
| October 30, 2024 | 430.01M |
| October 29, 2024 | 426.37M |
| October 28, 2024 | 445.61M |
| October 25, 2024 | 423.77M |
| October 24, 2024 | 426.89M |
| October 23, 2024 | 442.49M |
| October 22, 2024 | 429.49M |
| October 21, 2024 | 446.13M |
| October 18, 2024 | 443.53M |
| October 17, 2024 | 439.37M |
| Date | Value |
|---|---|
| October 16, 2024 | 450.29M |
| October 15, 2024 | 462.25M |
| October 14, 2024 | 469.53M |
| October 11, 2024 | 476.81M |
| October 10, 2024 | 453.93M |
| October 09, 2024 | 467.97M |
| October 08, 2024 | 487.73M |
| October 07, 2024 | 481.49M |
| October 04, 2024 | 518.41M |
| October 03, 2024 | 537.64M |
| October 02, 2024 | 534.01M |
| October 01, 2024 | 541.28M |
| September 30, 2024 | 562.08M |
| September 27, 2024 | 562.83M |
| September 26, 2024 | 569.59M |
| September 25, 2024 | 586.22M |
| September 24, 2024 | 597.13M |
| September 23, 2024 | 603.37M |
| September 20, 2024 | 618.44M |
| September 19, 2024 | 701.59M |
| September 18, 2024 | 874.13M |
| September 17, 2024 | 839.83M |
| September 16, 2024 | 856.46M |
| September 13, 2024 | 844.51M |
| September 12, 2024 | 826.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
183.46M
Minimum
Jun 16 2022
1.786B
Maximum
Mar 27 2024
731.81M
Average
706.36M
Median
May 21 2021
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 81.80B |
| Ocular Therapeutix Inc | 1.339B |
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
Market Cap Related Metrics
| PS Ratio | 23804.95 |
| PEG Ratio | -0.6366 |
| Price to Book Value | 0.6667 |
| Price | 7.975 |
| Earnings Yield | -35.74% |
| PEGY Ratio | -0.6366 |